Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 4 studies | 21% ± 2% |
Insufficient scRNA-seq data for expression of CARD10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1493.81 | 328 / 328 | 98% | 36.73 | 175 / 178 |
stomach | 100% | 1608.04 | 359 / 359 | 98% | 36.66 | 280 / 286 |
intestine | 99% | 2741.28 | 959 / 966 | 98% | 39.72 | 519 / 527 |
esophagus | 100% | 1629.48 | 1445 / 1445 | 96% | 31.54 | 176 / 183 |
liver | 100% | 2208.05 | 226 / 226 | 95% | 23.05 | 386 / 406 |
prostate | 98% | 1562.56 | 241 / 245 | 96% | 12.50 | 480 / 502 |
kidney | 100% | 3879.51 | 89 / 89 | 93% | 30.15 | 837 / 901 |
lung | 99% | 1623.47 | 575 / 578 | 86% | 17.09 | 989 / 1155 |
breast | 100% | 2741.26 | 459 / 459 | 85% | 14.07 | 945 / 1118 |
bladder | 100% | 1536.19 | 21 / 21 | 81% | 20.50 | 409 / 504 |
thymus | 100% | 1853.82 | 651 / 653 | 81% | 8.14 | 489 / 605 |
uterus | 100% | 1688.26 | 170 / 170 | 80% | 19.05 | 369 / 459 |
ovary | 94% | 757.48 | 169 / 180 | 82% | 12.05 | 352 / 430 |
adrenal gland | 100% | 2229.93 | 258 / 258 | 41% | 5.34 | 94 / 230 |
skin | 94% | 1762.01 | 1702 / 1809 | 39% | 4.57 | 184 / 472 |
spleen | 100% | 1134.83 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 2295.39 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 1254.08 | 846 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 16.92 | 40 / 45 |
muscle | 85% | 551.11 | 686 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 67% | 644.76 | 892 / 1335 | 0% | 0 | 0 / 0 |
brain | 23% | 107.58 | 602 / 2642 | 16% | 1.19 | 111 / 705 |
eye | 0% | 0 | 0 / 0 | 23% | 1.42 | 18 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.20 | 1 / 29 |
peripheral blood | 0% | 1.75 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090051 | Biological process | negative regulation of cell migration involved in sprouting angiogenesis |
GO_0007250 | Biological process | activation of NF-kappaB-inducing kinase activity |
GO_1900182 | Biological process | positive regulation of protein localization to nucleus |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0032449 | Cellular component | CBM complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0050700 | Molecular function | CARD domain binding |
GO_0030159 | Molecular function | signaling receptor complex adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CARD10 |
Protein name | Caspase recruitment domain family member 10 Caspase recruitment domain family, member 10 Caspase recruitment domain-containing protein 10 (CARD-containing MAGUK protein 3) (Carma 3) |
Synonyms | CARMA3 |
Description | FUNCTION: Scaffold protein that plays an important role in mediating the activation of NF-kappa-B via BCL10 or EGFR. . |
Accessions | B0QYC3 ENST00000251973.10 [Q9BWT7-1] ENST00000406271.7 [Q9BWT7-2] ENST00000433485.1 ENST00000403299.5 [Q9BWT7-1] Q9BWT7 B0QYC4 ENST00000437756.5 Q17RA1 |